Rare disease clinical trials present a distinct set of challenges that make sourcing strategies critical to study success. With fewer patients, limited historical data and small global treatment populations, every component of the trial must be executed with precision, especially the sourcing of comparator drugs and ancillary supplies. In rare disease studies patient recruitment is already difficult. Delays due to drug unavailability or supply chain inefficiencies can have a

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply chains, not just within the United States but worldwide. With the re-introduction of Trump-era tariffs on key goods, companies engaged in clinical research must rethink their sourcing and logistics strategies. Clinical Services International (CSI) is proactively addressing these challenges to support our clients amid this uncertain climate. Wh

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

Read our tips to help you reduce the risk associated with comparator sourcing Like all supply chains, comparator sourcing poses...

Here are three ways CSI helps you overcome challenges to ensure successful delivery of your clinical trial supplies Managing clinical...